Advertisement
Advertisement
U.S. Markets close in 8 mins
Advertisement
Advertisement
Advertisement
Advertisement

KPC Pharmaceuticals, Inc. (600422.SS)

Shanghai - Shanghai Delayed Price. Currency in CNY
Add to watchlist
12.32-0.22 (-1.75%)
At close: 03:00PM CST
Advertisement

KPC Pharmaceuticals, Inc.

No.166 Keyi Road
State New & High Tech Dev Zn
Kunming 650106
China
86 871 6831 9868
https://www.kpc.com.cn

Sector(s)Healthcare
IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Xianggang ZhongPresN/AN/AN/A
Mr. Lei WangChief Financial OfficerN/AN/A1985
Bo XieVP and Gen. Mang. of the Manufacturing CenterN/AN/A1971
Mr. Jun WangVPN/AN/A1977
Xiaoru WuVPN/AN/AN/A
Shenglong WuVPN/AN/AN/A
Zhenbo HuDirector and Exec. VPN/AN/AN/A
Zhang MengxunCompany Sec.N/AN/AN/A
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.

Description

KPC Pharmaceuticals, Inc., a pharmaceutical company, engages in the research and development, production, marketing, and commercial wholesale of botanical drugs in the People's Republic of China and internationally. It offers artemether, panax notoginseng, and gastrodine series drugs, as well as Chinese medicines and ethnic drugs under the Luotai, Tianxuanqing, Artemedine, Artem, and Arco brand names for treating cardio-cerebral-vascular and nervous system diseases, as well as malaria. The company also provides Dai medicines; antibiotics, chemical medicinal raw materials, chemical pharmaceutical preparations, traditional Chinese medicinal materials, biological products, biochemical drugs, and health foods; Amoxicillin, Cefaclor, Alfacalcidol, Artz, Snaplets, and Ribavirin spray products; glycyrrhizic acid; and GLP-1, a long-acting hypoglycemic drug. It markets artemisinin antimalarials, generic drugs, and medical apparatus. The company was formerly known as Kunming Pharmaceutical Corporation and changed its name to KPC Pharmaceuticals, Inc. in April 2015. KPC Pharmaceuticals, Inc. was founded in 1951 and is based in Kunming, the People's Republic of China.

Corporate Governance

KPC Pharmaceuticals, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement